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Childhood cancer is relatively rare, representing about 1% of cancers 
in the total population. The cumulative risk of developing cancer 
below the age of 15 years has been estimated to be between 1 and 
2.5 per 1 000.1 Childhood cancer is generally potentially curable, 
and progress towards cure has been made in developed countries 
where the overall survival rate for some common malignant tumours 
is about 80%.2 In South Africa, where children under 15 years 
(who constitute the paediatric population) represent 31% of the 
population,3 600 - 700 new cases of childhood malignancies have 
been reported yearly for the last 25 years to the South African 
Children’s Tumour Registry.
The Registry is essential for collecting data on malignant disease in 
the paediatric population. It is a central repository of data provided 
by individual, hospital-based registries throughout the country. 
These registries record data on all patients presenting to paediatric 
oncology services; however, children who die without being seen at a 
hospital, and those treated by private oncologists and other paediatric 
subspecialists (e.g. neurosurgeons), might not be recorded. Although 
a central registry of hospital-based registers cannot be complete, it 
nevertheless has data that can be used for statistical research in an 
efficient and sustainable way.
The Registry commenced in 1987 as an initiative of the South African 
Children’s Cancer Study Group (SACCSG). Paediatric oncology units 
in the country collaborate, and data also come from several oncologists 
and interested parties in private practice. All units have ethical approval 
to collect and submit data to the Registry. The Registry was hosted over 
time by various paediatric oncology units in the country; for the last 15 
years, it has been kept at Stellenbosch University.
There is no other dedicated children’s cancer registry in Africa, 
although the International Association of Cancer Registries has 60 
African members. However, only 17 of these are national registries; 
the rest are regional or hospital-based registries.4 The data in these 
registries include children and adults; therefore, some meaningful 
children’s data could be missed.
The Registry’s objectives
The objectives of the Registry are to determine: age-specific 
incidences; relative frequencies of various neoplasms; prevalence 
of childhood cancer; and individual tumours and their distribution 
according to age, sex, ethnicity and geographical area. It is used 
to assess subtype, stages of malignancies, and their outcomes in 
children. The collected information can assist in scientific analysis, 
planning and research.
The data collected in a hospital-based registry are: demographic 
information (name, age, sex, and address); tumour type, localisation 
and stage; histological type; treatment and outcome; and yearly 
follow-up results. Data should include the date and cause of death, if 
the patient died.5
Data are presented regularly at national and international meetings, 
and are used in Master’s dissertations or to provide information for 
analysis of specific tumours in different regions of the country. Data are 
accessible to all collaborating paediatric centres and released on written 
request to paediatric oncologists or other doctors working in the units.
Registry results
The Registry does not require substantial expenditure; it started 
and existed for more than 20 years without any financial support. 
The Childhood Cancer Foundation of South Africa has covered the 
Registry’s costs during the last 3 years, including salaries of 3 part-
time data capturers and a data manager; R30 000 for a computer, 
printer and scanner; and the data capturers’ training. The costs of 
the data capturers and data manager are currently R13 600 monthly.
Table 1 shows the childhood cancers recorded in the Registry 
from 1997 to 2007 by year and tumour type. The annual incidence of 
tumours in South African children aged 0 - 14 years varied between 
33.4 and 47.2 per million from 2003 to 2007, which is much lower 
than in the USA or Europe. In Europe, the annual incidence of cancer 
in this age group was 140 per million in 1990, increasing by 1% per 
year for the last 3 decades. This marked discrepancy is probably 
related to several factors, including failure to diagnose cancers, lack of 
referrals to oncology units, and failure to report them to the Registry.
In South Africa, leukaemia is the most common childhood 
cancer (25.4% of all cancers), which is similar to rates in other 
countries. While brain tumours and leukaemia comprise almost half 
of childhood cancers in developed countries, brain tumours represent 
only 13.4% of the total cancers diagnosed in children in South Africa. 
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The South African Children’s Tumour Registry was established 25 
years ago as it was essential to collect data on malignant disease in 
the paediatric population that can be used for statistical research 
in an efficient and sustainable way. The Registry is a useful and 
significant repository of specific paediatric data, along with the 
recently revitalised National Cancer Registry, to serve the needs of 
the cancer research community.
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This discrepancy can be explained by failure to consider or make the 
diagnosis, especially in smaller and rural hospitals.
Fig. 1 shows the distribution of the various childhood cancers for 
2 10-year periods. When these 2 periods are compared, the number 
of brain tumours decreased by half while epithelial tumours doubled, 
almost exclusively owing to the rising incidence of Kaposi’s sarcoma.
National Cancer Registry
Until April 2011, the Registry was the main source of statistical data 
for epidemiological studies in this field. An alternative source of 
cancer information was the National Cancer Registry, a pathology-
based registry of the National Health Laboratory Service, established 
in 1986. However, this source had shortcomings regarding children’s 
cancer: an unknown number of cases were not registered as they 
were diagnosed clinically, sometimes assisted by identifying tumour 
markers (e.g. hepatocellular carcinoma); and children were on the 
same register as adults (child-specific data may be missed). Clinical 
data were seldom communicated in full to the laboratories. Over time, 
many private laboratories discontinued contributing to the Register 
for fear of consequences arising from disclosure of information that 
might be private and confidential.6
Plans to revitalise the National Cancer Registry, initiated by 
the Department of Health, were finalised on 26 April 2011 with 
Government Notice No. R.380, which introduced new regulations 
in terms of the National Health Act, 2003 (Act No. 61 of 2003). All 
cancers in children and adults have to be reported to the National 
Cancer Registry. ‘The person in charge of a health establishment, 
where diagnosis is confirmed, must ensure that Annexure A is 
completed and submitted to the NCR within 3 months of diagnosis.’ 
Further, ‘The head of a laboratory must, on a quarterly basis, ensure 
that Annexure A, as well as the accompanying laboratory report, is 
completed and submitted to the NCR.’ The regulations stipulate that 
a population-based cancer registry will be established incrementally.
Conclusion
The SACCSG regards the Department of Health’s decision as an 
important step towards better understanding of the burden of disease 
owing to cancer and taking appropriate measures at national level 
to improve its management. Paediatric oncologists fully support the 
National Cancer Registry and report cases as requested. Nevertheless, 
we believe that the Registry remains a useful and significant repository 
for specific paediatric data that will, along with the National Cancer 
Registry, adequately address the needs of researchers in paediatric 
oncology.
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Fig. 1. The  proportional incidence ratios (PIRs) of the various cancer types 
in the periods 1987 - 1997 and 1998 - 2007. There is a decrease in the PIR of 
CNS  and an increase in epithelial tumours over the period. The other cancer 
subtypes show no change in PIR over the same period.
Table 1. Number of patients per year and diagnosis
1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 Total
Leukaemia 146 157 142 177 162 140 162 206 154 139 150 1 737
Lymphoma 69 83 66 98 85 83 88 86 98 78 89 923
CNS tumours 62 61 100 78 80 85 106 104 94 82 69 921
Nephroblastoma 64 85 75 84 104 62 72 94 71 73 61 845
Neuroblastoma 38 25 3 44 29 30 27 41 29 31 41 372
Rhabdomyosarcoma 40 44 35 55 48 41 42 42 57 52 33 487
Liver 12 7 13 17 17 14 12 8 13 14 16 143
Sarcoma 58 59 44 73 54 65 64 73 65 43 53 651
Bone 22 25 20 22 26 3 25 28 34 48 28 309
Other malignancy 15 19 16 44 25 26 22 22 16 19 15 238
Germ cell 20 27 27 24 20 21 20 17 19 15 13 223
Total 546 592 575 716 648 598 640 723 650 594 568 6 850
